Dow Jones Top Company Headlines at 3 AM ET: Novartis Says Neuromuscular Drug Candidate Misses Goal in Late-Stage Trial | EverBank ...

Novartis Says Neuromuscular Drug Candidate Misses Goal in Late-Stage Trial

The drug candidate was one of three therapies the Swiss pharmaceutical company added to its pipeline through its $12 billion acquisition of Avidity Biosciences.

----

EverBank to Combine With WaFd to Create $75 Billion Bank

Florida-based EverBank Financial has reached a deal to pursue a reverse merger with the smaller bank in the Pacific Northwest.

----

Mistral AI Exceeds $24 Billion Valuation After Samsung-Led Investment Round

The French artificial-intelligence startup said it had raised $3.48 billion from a pool of existing investors such as Samsung and ASML Holding, as well as new backers.

----

Robinhood Wins a New Role in the Oura IPO: Underwriter

Playing an official part in the IPO process could give Robinhood more influence over the number of shares allocated to its customers.

----

Amazon Plane Crash Probe Examines Aircraft Speed, Runway Safeguards

The NTSB chairwoman said the Boeing jet careened 1,300 feet off the runway, hitting a van with seven people.

----

Chinese Company Draws Fire for Laying Off 100 Grads a Month After Hiring Them

The major auto parts maker landed in hot water with authorities as young people in the country face a bleak job market.

----

The World Can't Get Enough of These Japanese Sneakers

Onitsuka Tigers are having a moment as a weak yen and classic looks lure tourists to Tokyo stores.

----

A $2,000 iPhone is coming soon as Apple aims for high-end buyers

Apple's launch event on Wednesday is likely to feature the iPhone 18 and 18 Pro - as well as a foldable iPhone Ultra with a starting price near $2,000.

----

How Nvidia's Investment Juggernaut Can Jump from Big to Enormous

Nvidia has big investments in Intel, SpaceX and many more public companies. But its stakes in OpenAI and Anthropic are the real prize.

----

Volkswagen Factory to Become Defense Plant in Deal With Israel's Aurelius

Under the deal, investment company Aurelius would take over the plant as majority owner, together with the state of Lower Saxony.

----

CXMT Highlights Smartphone, AI Advances as Market Share Climbs

The Chinese memory-chip maker sought to reassure investors that it is gaining ground in higher-end memory markets, citing advances in smartphone and artificial-intelligence technologies.

----

Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial

The Danish drugmaker said the clinical trial met its primary goal after 68 weeks of treatment.

----

Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial

The company said the late-stage study for its pelacarsen drug missed its primary objective of reducing the risk of cardiovascular events like death, heart attack and stroke compared with placebo.

(END) Dow Jones Newswires

September 08, 2026 03:00 ET (07:00 GMT)